GGrantIndex
← Search

Senior Leadership

$2,352,617P30FY2012CANIH

Vanderbilt University, Nashville TN

Investigators

Linked publications, trials & patents

Trial NCT07016399Trial NCT06593106Trial NCT05501665Trial NCT05361720Trial NCT04765072Trial NCT02702310Trial NCT02685631Trial NCT02677883Trial NCT02676752Trial NCT02672475Trial NCT02658487Trial NCT02600533Trial NCT02489422Trial NCT02480114Trial NCT02457910Trial NCT02448225Trial NCT02440737Trial NCT02374931Trial NCT02359851Trial NCT02324881Trial NCT02296112Trial NCT02269111Trial NCT02240381Trial NCT02236546Trial NCT02170272Trial NCT02151539Trial NCT02148406Trial NCT01996527Trial NCT01928160Trial NCT01901367Trial NCT01660971Trial NCT01230515Trial NCT01198535Trial NCT01141218Trial NCT01098669Trial NCT01098643Trial NCT01096407Trial NCT01096394Trial NCT01096381Trial NCT01077440Trial NCT01031446Trial NCT01013506Trial NCT01009931Trial NCT01007422Trial NCT00993694Trial NCT00993135Trial NCT00987766Trial NCT00984542Trial NCT00984490Trial NCT00983268Trial NCT00957736Trial NCT00949052Trial NCT00930930Trial NCT00900406Trial NCT00900003Trial NCT00899769Trial NCT00899626Trial NCT00899457Trial NCT00899301Trial NCT00899028Trial NCT00898742Trial NCT00898638Trial NCT00898430Trial NCT00898313Trial NCT00897988Trial NCT00897832Trial NCT00897793Trial NCT00897650Trial NCT00897468Trial NCT00897403Trial NCT00897117Trial NCT00896948Trial NCT00896675Trial NCT00892801Trial NCT00875238Trial NCT00840814Trial NCT00837876Trial NCT00835679Trial NCT00801346Trial NCT00765245Trial NCT00755040Trial NCT00675636Trial NCT00670644Trial NCT00670605Trial NCT00670046Trial NCT00666211Trial NCT00656604Trial NCT00653250Trial NCT00651976Trial NCT00651716Trial NCT00647218Trial NCT00626873Trial NCT00625417Trial NCT00625066Trial NCT00616590Trial NCT00601991Trial NCT00573404Trial NCT00550537Trial NCT00544648Trial NCT00533884

Abstract

Tlie Senior Leaders are responsible for tlie overall planning and operations of the programs and activities of the Vanderbilt-lngram Cancer Center (VICC). The Senior Leadership is comprised of the Director, Deputy Director and nine Associate Directors and has undergone transition during the current project period. As part of a planned succession following the successful 2003 competing renewal, Harold Moses, M.D., stepped down and Raymond DuBois, M.D., was named Director in in January 2005. Two years later he he left to become Provost and Executive Vice President of Academic Affairs at M.D. Anderson Cancer Center. Jennifer Pietenpol, Ph.D., then Associate Director for Basic Research, was asked to serve as interim director during a national search. In January 2008, she was selected as Director based on scientific accomplishments, leadership skills and administrative experience. Scott Hiebert, Ph.D., previously leader of the Signal Transduction and Cell Proliferation Research Program, was named Associate Director for Basic Science Research Programs in 2008 overseeing the basic science research programs and implementing the strategic plan for these programs. Also in 2008, William Blot, Ph.D., was named Associate Director for Cancer Prevention, Control and Population-Based Research. He provides senior leadership to the two coleaders of the Cancer Epidemiology, Prevention and Control Research Program. Four additional Associate Director positions have been added. Dr. Elizabeth Williams was recruited in 2005 as Associate Director for Minority Affairs with primary responsibility for health promotion, education, access to care, clinical trials and behavioral interventions for minority populations. Bettina Beech, Dr.P.H., was named in 2006 as Associate Director for Health Disparities Research, responsible for the promotion of health disparities research. In 2008, Beth Price, M.B.A., was named Associate Director for Administration and CEO and in 2009, Dr. Yu Shyr was named Associate Director for Quantitative Sciences Integration with oversight for integrating quantitative science throughout the center and facilitating VICC member access to complex genomic tools and analysis of high-dimensional data sets. Senior Leadership otherwise remains unchanged with David Johnson, M.D., as Deputy Director; Daniel Beauchamp, M.D., as Associate Director for Clinical Research Programs; Mark Magnuson, Ph.D., as Associate Director for Shared Resources; Ann Richmond, Ph.D., as Associate Director for Research Education; and Ms. Susan Mills as Associate Director for CCSG Administration.

View original record on NIH RePORTER →